Victor G. DeGruttola, Sc.D., M.S., is a professor of biostatistics and chair of the Department of Biostatistics at the Harvard School of Public Health. His research activities focus on developments of statistical methods required for appropriate public health response to the AIDS epidemic both within the United States and internationally. The aspects of the epidemic on which he has worked include transmission of, and natural history of infection with, HIV, as well as research on antiretroviral treatments, including the development and consequences of resistance and other adverse consequences of treatments. The broad goals of his research include developing treatment strategies that provide tolerable and durable virologic suppression while preserving treatment options after failure and evaluating the community-level impact of packages of prevention interventions, including antiviral treatment itself. He served as the director of the Statistics and Data Analysis Center of the Adult Project of the AIDS Clinical Trials Group during the period in which highly active antiretroviral treatment was developed, and he was instrumental in designing and analyzing studies of the best means of providing such therapy. Most recently, he has been engaged in development and application of methods for prevention of HIV infection.
Carlos del Rio, M.D., is the Hubert Professor and Chair of the Hubert Department of Global Health at the Rollins School of Public Health and professor of medicine in the Division of Infectious Diseases at the Emory University School of Medicine. He is also codirector of the Emory Center for AIDS Research. He has held numerous leadership roles including executive director of the National AIDS Council of Mexico, the federal agency of the Mexican government responsible for AIDS policy in that country; program director and principal investigator of the Emory AIDS International Training and Research Program; and member of the Board of the International AIDS Society–USA, the HIV Medicine Association, and the Infectious Diseases Society of America. Dr. del Rio’s research interests include the epidemiology of opportunistic infections in HIV and other immune deficiencies, the epidemiology and transmission dynamics of HIV and other sexually transmitted diseases, HIV testing, access to and retention in care, and compliance with antiretroviral drug regimens. He is also interested in the impact of HIV in developing countries and the optimal use of antiretroviral drugs in limited-resource settings. Dr. del Rio is associate editor of AIDS Clinical Care and senior clinical editor for AIDS Research and Human Retroviruses and is a member of the editorial board of Journal of AIDS and Global Public Health. He has coauthored more than 150 scientific papers.
Marshall Forstein, M.D., is an associate professor of psychiatry at Harvard Medical School and director of Adult Psychiatry Residency Training at the